van Faassen HJR - Search Results

1

The increasing importance of LNAA supplementation in phenylketonuria at higher plasma phenylalanine concentrations.

van Vliet D, van der Goot E, van Ginkel WG, van Faassen HJR, de Blaauw P, Kema IP, Heiner-Fokkema MR, van der Zee EA, van Spronsen FJ. van Vliet D, et al. Among authors: van faassen hjr. Mol Genet Metab. 2022 Jan;135(1):27-34. doi: 10.1016/j.ymgme.2021.11.003. Epub 2021 Dec 14. Mol Genet Metab. 2022. PMID: 34974973

2

Towards optimal personalized diet and vitamin supplementation in NET patients.

de Hosson LD, Stelwagen J, Bouma G, Sijtema B, Huitema S, van Faassen HJR, de Bock GH, de Groot DJA, Campmans-Kuijpers MJE, Kema IP, de Vries EGE, Walenkamp AME. de Hosson LD, et al. Among authors: van faassen hjr. Endocr Relat Cancer. 2018 Mar;25(3):L23-L26. doi: 10.1530/ERC-17-0549. Endocr Relat Cancer. 2018. PMID: 29431642 Clinical Trial. No abstract available.

3

Tyrosinaemia type I: orthotopic liver transplantation as the only definitive answer to a metabolic as well as an oncological problem.

van Spronsen FJ, Berger R, Smit GP, de Klerk JB, Duran M, Bijleveld CM, van Faassen H, Slooff MJ, Heymans HS. van Spronsen FJ, et al. J Inherit Metab Dis. 1989;12 Suppl 2:339-42. doi: 10.1007/BF03335416. J Inherit Metab Dis. 1989. PMID: 2556611 Review. No abstract available.

4

Hereditary tyrosinaemia type I: a long-term study of the relationship between the urinary excretions of succinylacetone and delta-aminolevulinic acid.

Schierbeek H, Beukeveld GJ, van Faassen H, van Spronsen FJ, Bijsterveld K, Venekamp-Hoolsema EE, Wolthers BG, Smit GP. Schierbeek H, et al. J Inherit Metab Dis. 1993;16(6):1034-40. doi: 10.1007/BF00711521. J Inherit Metab Dis. 1993. PMID: 8127053

5

Separation of different forms of S-adenosylmethionine synthetase by fast protein liquid chromatography.

van Faassen H, Berger R. van Faassen H, et al. J Biochem Biophys Methods. 1990 Mar;20(3):189-94. doi: 10.1016/0165-022x(90)90077-p. J Biochem Biophys Methods. 1990. PMID: 2345265

6

Purification of human liver fumarylacetoacetase using immunoaffinity chromatography.

van Faassen H, van den Berg IE, Berger R. van Faassen H, et al. J Biochem Biophys Methods. 1990 Apr-May;20(4):317-24. doi: 10.1016/0165-022x(90)90093-r. J Biochem Biophys Methods. 1990. PMID: 2195095

7

Type I tyrosinemia: lack of immunologically detectable fumarylacetoacetase enzyme protein in tissues and cell extracts.

Berger R, Van Faassen H, Taanman JW, De Vries H, Agsteribbe E. Berger R, et al. Pediatr Res. 1987 Oct;22(4):394-8. doi: 10.1203/00006450-198710000-00005. Pediatr Res. 1987. PMID: 3317254

8

Nucleotide sequence of cDNA encoding human fumarylacetoacetase.

Agsteribbe E, van Faassen H, Hartog MV, Reversma T, Taanman JW, Pannekoek H, Evers RF, Welling GM, Berger R. Agsteribbe E, et al. Nucleic Acids Res. 1990 Apr 11;18(7):1887. doi: 10.1093/nar/18.7.1887. Nucleic Acids Res. 1990. PMID: 2336361 Free PMC article. No abstract available.

9

Biochemical studies on the enzymatic deficiencies in hereditary tyrosinemia.

Berger R, van Faassen H, Smith GP. Berger R, et al. Clin Chim Acta. 1983 Oct 31;134(1-2):129-41. doi: 10.1016/0009-8981(83)90191-2. Clin Chim Acta. 1983. PMID: 6652907

10

Hereditary tyrosinemia type I: lack of correlation between clinical findings and amount of immunoreactive fumarylacetoacetase protein.

Kvittingen EA, Rootwelt H, van Dam T, van Faassen H, Berger R. Kvittingen EA, et al. Pediatr Res. 1992 Jan;31(1):43-6. doi: 10.1203/00006450-199201000-00008. Pediatr Res. 1992. PMID: 1594329

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters